Evaluation of a passive hemagglutination assay as screening test and of a recombinant immunoblot as confirmatory test for serological diagnosis of Lyme disease
โ Scribed by A. Hamann-Brand; M. Flondor; V. Brade
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 690 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
At this present time, we feel that there is no role for DNA flow cytometry (FCM), or indeed DNA studies by any other method, to be used as a screening procedure for patients with no prior history of bladder cancer due to the high false-positive rate found when monitoring exfoliated urothelial cells.
To assess the performance of different cutoff points for fasting plasma glucose (FPG) including the World Health Organization (WHO) cutoff of FPG ั7.8 mmol l -1 for the screening of diabetes mellitus, data from oral glucose tolerance tests done on 865 Singaporean adults over a 4-year period were ana
The potential value of in vitro cytotoxic T lymphocyte (CTL) assays for predicting the occurrence of graft vs host disease (GVHD) following allogeneic bone marrow transplantation was evaluated in 12 mouse donor-host combinations associated with various degrees of GVHD. These donor-host combinations